🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Cliff Asness’s GSK Holdings & Trades

First Buy
Q1 2024
Duration Held
10 Quarters
Largest Add
Q3 2025
+150,316 Shares
Current Position
346,157 Shares
$18.15 M Value

Cliff Asness's GSK Position Overview

Cliff Asness (via Aqr Capital Management LLC) currently holds 346,157 shares of GSK plc (GSK) worth $18.15 M, representing 0.01% of the portfolio. First purchased in 2024-Q1, this medium-term investment has been held for 10 quarters.

Based on 13F filings, Cliff Asness has maintained a strategic position in GSK, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 150,316 shares. Largest reduction occurred in Q4 2024, reducing 5,636 shares.

Analysis based on 13F filings available since 2013 Q2

Cliff Asness's GSK plc (GSK) Holding Value Over Time

Track share changes against reported price movement

Quarterly GSK plc (GSK) Trades by Cliff Asness

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q2 2026 +63,034 Add 22.26% 346,157 $52.42
Q1 2026 +46,521 Add 19.66% 283,123 $55.19
Q4 2025 +32,996 Add 16.21% 236,602 $49.04
Q3 2025 +150,316 Add 282.07% 203,606 $43.16
Q2 2025 +13,051 Add 32.43% 53,290 $38.40
Q1 2025 +18,420 Add 84.42% 40,239 $38.74
Q4 2024 -5,636 Reduce 20.53% 21,819 $33.82
Q3 2024 +1,092 Add 4.14% 27,455 $40.88
Q2 2024 +13,403 Add 103.42% 26,363 $38.50
Q1 2024 +12,960 New Buy 12,960 $42.87

Cliff Asness's GSK plc Investment FAQs

Cliff Asness first purchased GSK plc (GSK) in Q1 2024, acquiring 12,960 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Cliff Asness has held GSK plc (GSK) for 10 quarters since Q1 2024.

Cliff Asness's largest addition to GSK plc (GSK) was in Q3 2025, adding 203,606 shares worth $8.79 M.

According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 346,157 shares of GSK plc (GSK), valued at approximately $18.15 M.

As of the Q2 2026 filing, GSK plc (GSK) represents approximately 0.01% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.

Cliff Asness's peak holding in GSK plc (GSK) was 346,157 shares, as reported at the end of Q2 2026.